Prakt. Lékáren. 2016; 12(3e) [Interní Med. 2015; 17(5): 230-232]

The Damage of Gastrointestinal Tract Mucosa Caused by Non-Steroidal Anti-Inflammatory Agents and Other Drugs

Pavel Svoboda, Petr Dítě
Interní klinika FN Ostrava, Lékařská fakulta Ostravské univerzity, Ostrava

Nonsteroidal anti-inflammatory agents are drugs that are frequently linked to side effects; in the Czech Republic approximately 500 000–600 000persons use them for treatment and at least 300 patients a year die from complications caused by the treatment. NSAID-related gastropathy manifests itself in the appearance of gastric or duodenal mucosa alterations such as erosions and petechia (50%), ulcers (5–30%), aphthae,mucosal erythema, or in complications (1–2%), particularly in upper GIT bleeding and perforation. Clinical effects include dyspeptic syndromeor anaemia. There is, however, low correlation between subjective symptoms and the endoscopic picture. Recommended treatment consistsin the discontinuation or reduction of the use of NSAID, testing for and treating Helicobacter pylori, and the administration of proton-pumpinhibitors. NSAID-related enteropathy includes alterations in intestinal permeability, ulcers, strictures, bleeding, or perforation. The conditionmay manifest itself in occult bleeding and the development of anaemia, or in the loss of proteins and the appearance of hypalbuminemiea,diarrhoea, weight loss. Strictures may cause colicky abdominal pain or a subileus condition. Inflammatory alterations and occult bleeding arereduced by metronidazole. The therapy also employs sulfasalazine and probiotics. Due to these factors the indication for the use of non-steroidalanti-inflammatory drugs should always be carefully considered.

Keywords: peptic ulcer, non-steroidal anti-inflammatory drugs, NSAID, gastropathy, enteropathy, gastrointestinal tract

Published: July 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Svoboda P, Dítě P. The Damage of Gastrointestinal Tract Mucosa Caused by Non-Steroidal Anti-Inflammatory Agents and Other Drugs. Praktické lékárenství. 2016;12(E-verze 3/16):.
Download citation

References

  1. Bytzer P. Dyspepsia and an adverse effect of drugs. Best Pract a Res Clin Gastroenterol 2010; 24(2): 109-120. Go to original source... Go to PubMed...
  2. Singh H, Triadafilopoulos G. Epidemiology of NSA-induced GI complications. J Rheumatol 1999; 26: 18-24.
  3. Larkai EN, Smith JL, Lidsky MD, Graham DY: Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic steroidal antiinflammatory drug use. Am J Gastroenterol 1987; 82: 1153-1158.
  4. Bombardier, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis, N Engl J Med 2000; 343: 1520-1528. Go to original source... Go to PubMed...
  5. Talley NJ, Evans JM, Fleming KC et al. Nonsteroidal antiinflammatory drug and dyspepsia in the elderly. Gig Dis 1995; 40: 1345-1350. Go to original source... Go to PubMed...
  6. Vonkemann HE, van der Laar M, Nonsteroidal anti-inflammatory drugs: averse effect and thein preventiv. Semin Arthritis Rheum 2010; 39: 294-312. Go to original source... Go to PubMed...
  7. Martínek J, Lukáš M. Inhibitory protonové pumpy: Up to date. Gastroent Hepatol 2011; 65(6): 331-342.
  8. Serrano, et al. Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases, Aliment Pharmacol Ther 2002; 16: 1945-1953. Go to original source... Go to PubMed...
  9. Rybár I, Hyrdel R, Rovenský J. Peptické léze navozené léčbou nesteroidními antiflogistiky. In Jurgoš L, Kužela L, Hrušovský, et al. Gastroenterologia. VEDA Bratislava; 2006: 289-297.
  10. Shih SC, Chang CW, Nonsteroidal anti-inflammatory drug-related gastrointestinal bleeding in the elderly. Intern J Gerontol 2007; 1(1): 40-45. Go to original source...
  11. Martínek J, Špičák J, Pantoflíčková G. Helicobacter pylori a peptický vřed: Co nového. Čes. a Slov Gastroent 2000; 1: 24-34.
  12. Gusta M, Eisen GM, NDAIDs and the gastrointestinal tract. Curr gastroenterol Rep 2009; 11(5): 345-353. Go to original source... Go to PubMed...
  13. Laine, et al. Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use, Gastroenterology 2003; 124: 288-292. Go to original source... Go to PubMed...
  14. Maiden L, Thjodleifsson B, Seigal A, et al. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study. Clin Gastroenterol Hepatol 2007; 5: 1040-1045. Go to original source... Go to PubMed...
  15. Jones MK, Wang H, Peskar BM, et al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999; 5: 1418-1423. Go to original source... Go to PubMed...
  16. Somasundaram S, Rafi S, Hayllar J, et al. Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced Indry to the rat intestine. Gut 1997; 41: 344-353. Go to original source... Go to PubMed...
  17. Wallace LJ. Mechanisms, prevention and clinical implications of nosteroidal anti-inflammatory drug-enteropathy. World J Gastroenterol 2013; 19(12): 1861-1876. Go to original source... Go to PubMed...
  18. Bjarnason I, Hayllar J, Smethurst P, et al. Metronidazole reduces intestinal inflammation and blood loss in nonsteroidal anti-inflammatory drug induced enteropathy. GUT 1990; 33: 1204. Go to original source... Go to PubMed...
  19. Kinouchi T, Kataoka K, Bing SR, et al. Culture supernatants of Lactobacillus acidophilus and Bifidobacterium adolescentis repress ileal ulcer formation in rats treated with a nonsteroidal antiinflammatory drug by suppressing unbalanced growth of aerobic bacteria and lipid peroxidation. Microbiol Immunol 1998; 42: 347-355. Go to original source... Go to PubMed...
  20. Delon ES, Shaheen NJ. Miscellaneous diseases of the esofagus. In: Textbook of gastroenterology, Yamada T, Willey-Blackwell Chichester, Hoboken 2009; 871-888. Go to original source...
  21. Tutian R, Adverse effects of drugs on the esophagus. Best Pract a Res Clin Gastroenterol 2010; 24(2): 91-97. Go to original source... Go to PubMed...
  22. Pandeya N, Webb PM, Sadeghi S, et al. Australian cancer study: Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid supressants? Gut 2010; 59(1): 31-38. Go to original source... Go to PubMed...




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.